Healthy individuals - post-iron for Anoxia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Colorado Anschutz Medical Campus, Aurora, CO
Anoxia+2 More
Ferrous sulfate 325mg - Drug
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this study is to determine if taking iron supplement pills improves exercise performance in low-oxygen conditions.

Eligible Conditions

  • Anoxia
  • Ventricular Dysfunction, Right

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Anoxia

Study Objectives

2 Primary · 6 Secondary · Reporting Duration: Up to 1 hour

Up to 1 hour
Maximal oxygen uptake
Maximum workload
Oxygen saturation at peak exercise
Pulmonary artery systolic pressure measured by echocardiography
Submaximal Stage 1 workload
Submaximal Stage 2 workload
Tricuspid annular plane systolic excursion measured by echocardiography
Ventilatory threshold

Trial Safety

Safety Progress

1 of 3

Other trials for Anoxia

Trial Design

2 Treatment Groups

Healthy individuals - post-iron
1 of 2
Healthy individuals - pre-iron
1 of 2
Active Control
Non-Treatment Group

5 Total Participants · 2 Treatment Groups

Primary Treatment: Healthy individuals - post-iron · Has Placebo Group · Phase < 1

Healthy individuals - pre-iron
Drug
PlaceboComparator Group · 1 Intervention: Ferrous sulfate 325mg · Intervention Types: Drug
Healthy individuals - post-iron
Drug
ActiveComparator Group · 1 Intervention: Ferrous sulfate 325mg · Intervention Types: Drug

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 1 hour
Closest Location: University of Colorado Anschutz Medical Campus · Aurora, CO
Photo of aurora 1Photo of aurora 2Photo of aurora 3
2015First Recorded Clinical Trial
0 TrialsResearching Anoxia
91 CompletedClinical Trials

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,554 Previous Clinical Trials
1,910,523 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are aged 18 to 60 years.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References